![Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India in: The American Journal of Tropical Medicine and Hygiene Volume 105 Issue 2 (2021) Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India in: The American Journal of Tropical Medicine and Hygiene Volume 105 Issue 2 (2021)](https://www.ajtmh.org/view/journals/tpmd/105/2/full-tpmd210014f1.jpg)
Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India in: The American Journal of Tropical Medicine and Hygiene Volume 105 Issue 2 (2021)
![SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women - eBioMedicine SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women - eBioMedicine](https://www.thelancet.com/cms/asset/ffc3dab9-8c47-413d-80d6-a1279a74f8bf/gr1.jpg)
SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women - eBioMedicine
High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model | PLOS ONE
![Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology](https://www.science.org/cms/asset/370065e6-9aa7-487e-bb18-ad49de12ac0d/abe0240-f1.gif)
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology
![Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates | Virology Journal | Full Text Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates | Virology Journal | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12985-018-1026-3/MediaObjects/12985_2018_1026_Fig3_HTML.png)
Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates | Virology Journal | Full Text
![Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits | Science Translational Medicine Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abc3539/asset/bdba9b98-f069-4fd2-8eb4-1f9058d311f6/assets/graphic/abc3539-f1.jpeg)
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits | Science Translational Medicine
![Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods | Cellular & Molecular Immunology Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods | Cellular & Molecular Immunology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41423-020-00573-9/MediaObjects/41423_2020_573_Fig2_HTML.png)
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods | Cellular & Molecular Immunology
![JCI Insight - Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19 JCI Insight - Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19](https://df6sxcketz7bb.cloudfront.net/manuscripts/146000/146267/medium/jci.insight.146267.f4.jpg)
JCI Insight - Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19
![Neutralizing antibody serologic assay kits for SARS-CoV-2 and its variants : Get Quote, RFQ, Price or Buy Neutralizing antibody serologic assay kits for SARS-CoV-2 and its variants : Get Quote, RFQ, Price or Buy](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2021/9/1serology_14-1.jpg)
Neutralizing antibody serologic assay kits for SARS-CoV-2 and its variants : Get Quote, RFQ, Price or Buy
![Vaccines | Free Full-Text | Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination Vaccines | Free Full-Text | Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination](https://pub.mdpi-res.com/vaccines/vaccines-10-00796/article_deploy/html/images/vaccines-10-00796-g001.png?1652977095)
Vaccines | Free Full-Text | Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination
![Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis - The Lancet Microbe Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis - The Lancet Microbe](https://www.thelancet.com/cms/attachment/514f4361-6a8c-4798-b96a-f6f73f342a18/gr1_lrg.jpg)